Video guest: Josephine Mwangi

July 2018
25 26 27 28 29 30 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 1 2 3 4 5



Follow the CTA Brussels Daily


twitter logo


facebook logo cta

Friday, 07 December 2012

Our Video Guest: Clive Ondari, WHO

We have met with Dr. Clive Ondari, Coordinator of Access to Medicines, Department of Essential Medicines and Health Products, World Health Organization to discuss the efforts that the EU and the WHO make in order to fight Malaria in Africa, and the specificities of the "Working with African countries to ensure a pharmaceutical quality response to malaria" project.
According to a study conducted by the World Health Organization (WHO) in 2003 in the Cameroon, Ethiopia, Ghana, Kenya, Nigeria and Tanzania more than 50% of the anti-malaria medicine did not respond basic quality requirements.
In order to address this problem, the EU and the WHO carried out a project- "Working with African countries to ensure a pharmaceutical quality response to malaria"- aimed at developing national regulatory frameworks for anti-malaria medicine quality in these six African countries.
At the end of the project in 2012 the total medicine failure rate dropped to 28,5%. The largest rate of failure was registered in Cameroon (with more than 60% rate of failure among tested medicine), while the smallest was registered in Ethiopia (with 0% failure rate).
It is estimated that in 2010 there were 216 million cases of malaria, resulting in 655,000 deaths. 81% of these cases and 91% of deaths happened in Africa.